NDC properties for NDC 9 51759-361
NDC item 51759036103
NDC 9 | 51759-361 |
---|---|
NDC 10 | 51759-361-03 |
NDC Item | 51759036103 |
packaging | 3 KIT in 1 CARTON (51759-361-03) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
BLA | BLA761299 |
Labeler | Teva Pharmaceuticals USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-02-28 |
Marketing status | active |
NDC item 51759036117
NDC 9 | 51759-361 |
---|---|
NDC 10 | 51759-361-17 |
NDC Item | 51759036117 |
packaging | 1 KIT in 1 CARTON (51759-361-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
BLA | BLA761299 |
Labeler | Teva Pharmaceuticals USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-02-28 |
Marketing status | active |